Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. KFY
5. ABBV
6. MU
7. DPZ
8. NAVN
9. DFTX
10. NVEC

Go back to Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics (NTLA) Tops Q1 EPS by 17c

May 8, 2025 7:31 AM EDT

Intellia Therapeutics (NASDAQ: NTLA) reported Q1 EPS of ($1.10), $0.17 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $16.63 million versus the consensus estimate of $12.79 million.

For earnings history and earnings-related data on Intellia Therapeutics (NTLA) click here.

... More